首页> 外文期刊>Annals of allergy, asthma, and immunology >Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma
【24h】

Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma

机译:迅速发作了北欧司布对早期峰值呼气流动的严重,不受控制的哮喘

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Benralizumab is a unique eosinophil-depleting monoclonal antibody that significantly reduces asthma exacerbations, improves lung function and asthma symptoms, and permits the reduction of maintenance oral corticosteroid dosage for patients with severe, uncontrolled eosinophilic asthma.
机译:背景:Benralizumab是一种独特的嗜酸性粒细胞耗尽单克隆抗体,可显着降低哮喘发作,提高肺功能和哮喘症状,并允许减少严重,不受控制的嗜酸性哮喘患者的维持口服皮质类固醇剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号